Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥109.83 Million ≈ $16.07 Million USD) by net assets (CN¥2.41 Billion ≈ $352.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Shanghai Shenqi Pharmaceutical Investmen to measure how much of total assets are equity-financed.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shanghai Shenqi Pharmaceutical Investmen (600613) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Xinchai Co. Ltd. SHE:301032	N/A
Taiwan Mask Corp TW:2338	0.116x
DongGuan Winnerway Industrial Zone Ltd SHE:000573	-0.006x
Contango ORE Inc NYSE MKT:CTGO	0.487x
Evolent Health Inc NYSE:EVH	-0.002x
Dimerco Express TWO:5609	0.001x
Oxiquim S.A SN:OXIQUIM	0.051x
Meshflow Acquisition Corp. Class A Ordinary Shares NASDAQ:MESH	-0.001x

Annual Cash Flow Conversion Efficiency for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600613 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.40 Billion ≈ $350.83 Million	CN¥124.47 Million ≈ $18.21 Million	0.052x	-39.36%
2024-12-31	CN¥2.43 Billion ≈ $355.12 Million	CN¥207.79 Million ≈ $30.41 Million	0.086x	-5.06%
2023-12-31	CN¥2.39 Billion ≈ $349.81 Million	CN¥215.59 Million ≈ $31.55 Million	0.090x	-32.96%
2022-12-31	CN¥2.37 Billion ≈ $347.27 Million	CN¥319.23 Million ≈ $46.71 Million	0.135x	+74.66%
2021-12-31	CN¥2.39 Billion ≈ $350.10 Million	CN¥184.26 Million ≈ $26.96 Million	0.077x	+80.90%
2020-12-31	CN¥2.33 Billion ≈ $340.61 Million	CN¥99.10 Million ≈ $14.50 Million	0.043x	-11.67%
2019-12-31	CN¥2.66 Billion ≈ $389.47 Million	CN¥128.28 Million ≈ $18.77 Million	0.048x	-15.67%
2018-12-31	CN¥2.60 Billion ≈ $380.28 Million	CN¥148.53 Million ≈ $21.73 Million	0.057x	+115.90%
2017-12-31	CN¥2.53 Billion ≈ $370.30 Million	CN¥66.99 Million ≈ $9.80 Million	0.026x	+11200.00%
2016-12-31	CN¥2.43 Billion ≈ $356.31 Million	CN¥570.41K ≈ $83.47K	0.000x	-98.22%
2015-12-31	CN¥2.29 Billion ≈ $334.49 Million	CN¥30.12 Million ≈ $4.41 Million	0.013x	+405.40%
2014-12-31	CN¥2.00 Billion ≈ $292.37 Million	CN¥-8.62 Million ≈ $-1.26 Million	-0.004x	-110.46%
2013-12-31	CN¥1.81 Billion ≈ $265.15 Million	CN¥74.75 Million ≈ $10.94 Million	0.041x	+183.60%
2012-12-31	CN¥226.61 Million ≈ $33.16 Million	CN¥-11.18 Million ≈ $-1.64 Million	-0.049x	-213.50%
2011-12-31	CN¥211.50 Million ≈ $30.95 Million	CN¥-3.33 Million ≈ $-487.11K	-0.016x	-109.17%
2010-12-31	CN¥192.37 Million ≈ $28.15 Million	CN¥33.04 Million ≈ $4.83 Million	0.172x	+309.61%
2009-12-31	CN¥183.43 Million ≈ $26.84 Million	CN¥7.69 Million ≈ $1.13 Million	0.042x	-65.35%
2008-12-31	CN¥208.82 Million ≈ $30.56 Million	CN¥25.26 Million ≈ $3.70 Million	0.121x	+54.40%
2007-12-31	CN¥204.29 Million ≈ $29.89 Million	CN¥16.01 Million ≈ $2.34 Million	0.078x	+344.25%
2006-12-31	CN¥188.49 Million ≈ $27.58 Million	CN¥-6.05 Million ≈ $-884.87K	-0.032x	-118.13%
2005-12-31	CN¥184.92 Million ≈ $27.06 Million	CN¥32.72 Million ≈ $4.79 Million	0.177x	+528.48%
2004-12-31	CN¥176.21 Million ≈ $25.79 Million	CN¥4.96 Million ≈ $725.94K	0.028x	-6.34%
2003-12-31	CN¥150.23 Million ≈ $21.98 Million	CN¥4.52 Million ≈ $660.84K	0.030x	-72.58%
2002-12-31	CN¥146.14 Million ≈ $21.38 Million	CN¥16.02 Million ≈ $2.34 Million	0.110x	+234.59%
2001-12-31	CN¥251.84 Million ≈ $36.85 Million	CN¥-20.51 Million ≈ $-3.00 Million	-0.081x	-209.56%
2000-12-31	CN¥361.16 Million ≈ $52.85 Million	CN¥26.85 Million ≈ $3.93 Million	0.074x	+864.07%
1999-12-31	CN¥336.74 Million ≈ $49.28 Million	CN¥-3.28 Million ≈ $-479.48K	-0.010x	-104.86%
1998-12-31	CN¥363.26 Million ≈ $53.16 Million	CN¥72.67 Million ≈ $10.63 Million	0.200x	--

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

SHG:600613 China Drug Manufacturers - General

Market Cap

$346.49 Million

CN¥2.37 Billion CNY

Market Cap Rank

#14107 Global

#4194 in China

Share Price

CN¥4.94

Change (1 day)

-1.59%

52-Week Range

CN¥4.44 - CN¥7.19

All Time High

CN¥24.35